Preclinical vaccine adjuvant and therapeutic drug manufacturing
Analytik’s microfluidizer helps more and more pharmaceutical companies and contract manufacturing organizations (CDMOs) improve drug efficacy, bioavailability, stability, and process efficiency by uniformly reducing particle size. I am supporting. Today, Analytik’s Microfluidizer® technology is widely seen as the gold standard for scalable and uniform particle size reduction in vaccine adjuvants, dispersions, liposomes, and cell disruption manufacturing processes.
Read more...